{
  "meta": {
    "title": "268_Paediatrics_Ini-Cet_2023",
    "url": "https://brainandscalpel.vercel.app/268-paediatrics-ini-cet-2023-53c08bf6.html",
    "scrapedAt": "2025-11-30T12:57:38.309Z"
  },
  "questions": [
    {
      "text": "In a baby born with meconium-stained liquor, which of the following are recommended as per Neonatal Resuscitation guidelines?<div class='question-desc-html'><ol>\n<li>Intrapartum suction of nose and mouth before delivery of shoulder</li>\n<li>Intratracheal suction in case of nonvigorous baby</li>\n<li>Gentle suction of nose and mouth in case of vigorous baby</li>\n<li>PPV in case of non vigorous baby after early steps</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2, 3, 4"
        },
        {
          "id": 2,
          "text": "2, 4"
        },
        {
          "id": 3,
          "text": "3, 4"
        },
        {
          "id": 4,
          "text": "1, 3, 4"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<div>In a baby born with¬†meconium-stained liquor, <strong>gentle suction</strong> of the nose and mouth is done in the case of a <strong>vigorous</strong> <strong>baby¬†</strong>(Statement 3)<strong>,</strong> and <strong>positive pressure ventilation (PPV)</strong> is done in the case of a <strong>non-vigorous baby</strong> after early steps (Statement 4).</div>\n<div>¬†</div>\n<div>A baby born through meconium-stained liquor is classified as either a vigorous baby or a non-vigorous baby. A <strong>vigorous bab</strong>y has <strong>good breathing</strong> and <strong>normal tone</strong>, whereas, a<strong> non-vigorous baby</strong> has <strong>poor</strong> or <strong>no breathing</strong> with <strong>decreased tone</strong>.¬†According to neonatal resuscitation guidelines, in a vigorous baby, gentle suction is done and the baby is kept with the mother. In a non-vigorous baby, the initial steps of resuscitation are done and is followed by PPV if the baby is not responding. Routine tracheal suctioning is <strong>not</strong> recommended (Statement 2).¬†</div>\n<div>¬†</div>\n<div><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">The response to neonatal resuscitation at various steps is assessed based on the heart rate.</span></div>\n<ul class=\"listtype-bullet listindent1 list-bullet1\">\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>If </strong>the<strong> heart rate </strong>is<strong> less than 100</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">, </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>PPV </strong>(positive pressure ventilation)<strong>¬†</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">is provided with bag and mask and </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>SPO2 monitoring¬†</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">is done and </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>adequate¬†</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>ventilation¬†</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">is ensured.</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">If the </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>heart rate </strong>is<strong> below 60</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">, then </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>chest¬†</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>compressions¬†</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">are initiated over the lower third of the sternum at a rate of <strong>90 compressions/min</strong>.</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Recommended rate of ventilation is 30 inflations/min. (90 compressions + 30 inflation = 120 events/ min). The ratio of compressions to ventilation is <strong>3: 1.</strong></span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">If the heart rate still remains &lt;60, despite effective compressions and ventilation, then IV epinephrine is given.</span></li>\n</ul>\n<p><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Note: For any baby, intrapartum suction of nose and mouth before delivery of shoulder is <strong>not</strong> recommended. (Statement 1)</span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a93e19c6560145aca39469f332e775acx1280x2558.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9151",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following has the least risk of perinatal transmission?",
      "choices": [
        {
          "id": 1,
          "text": "HSV"
        },
        {
          "id": 2,
          "text": "CMV"
        },
        {
          "id": 3,
          "text": "Rubella"
        },
        {
          "id": 4,
          "text": "Hepatitis B"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Rubella¬†</strong>has the <strong>least risk</strong> of <strong>perinatal transmission</strong>.¬†</p>\n<p>Rubella or <strong>German measles</strong> has an <strong>intrauterine transmission</strong> that causes serious infection in pregnancy which results in¬†<strong>abortions</strong>¬†or¬†<strong>severe fetal defects</strong>¬†if infection occurs in the¬†<strong>first trimester.¬†</strong>The classical triad of congenital rubella syndrome is¬†<strong>deafness, cataract</strong>,¬†and¬†<strong>congenital heart disease</strong>.</p>\n<p>Other options-¬†</p>\n<p>Option A: <strong>Herpes simplex infection</strong> can be acquired¬†<strong>in utero, intrapartum/perinatally, </strong>or during the <strong>neonatal period</strong>. The¬†<strong>intrauterine</strong>¬†infection causes¬†<strong>skin vesicles, eye findings</strong>¬†(chorioretinitis, keratoconjunctivitis)<strong>,¬†</strong>and¬†<strong>microcephaly/hydranencephaly. Intrapartum¬†</strong>infection presents with either:</p>\n<ul>\n<li>Skin, eye, and mouth disease</li>\n<li>Encephalitis</li>\n<li>Disseminated disease with sepsis-like presentation</li>\n</ul>\n<p>Option B:<strong> Cytomegalovirus</strong>, the <strong>most common congenital infection with perinatal transmission</strong> presents with hepatosplenomegaly,¬†<strong>petechial</strong>¬†<strong>rashes</strong>,¬†<strong>jaundice</strong>,¬†<strong>chorioretinitis</strong>, and microcephaly. One of the long-term sequelae is<strong>¬†hearing loss.¬†</strong></p>\n<p>Option D:<strong> Hepatitis B</strong> virus is associated with <strong>significant perinatal transmission</strong>.¬†The most important <strong>risk factor</strong> that determines perinatal transmission is <strong>HBeAg</strong>.</p>\n<p>¬†</p><hr><h3>Related Pearl: The Hepatitis Viruses</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>HAV</td>\n<td>HBV</td>\n<td>HCV</td>\n<td>HDV</td>\n<td>HEV</td>\n</tr>\n<tr>\n<td>Specific name</td>\n<td>Hepatovirus A</td>\n<td>Hepatitis B virus</td>\n<td>Hepacivirus C</td>\n<td>Hepatitis D virus</td>\n<td>Orthohepevirus A</td>\n</tr>\n<tr>\n<td>Family</td>\n<td>Picornaviridae</td>\n<td>Hepadnaviridae</td>\n<td>Flaviviridae</td>\n<td>Kolmioviridae (genus deltavirus)</td>\n<td>Hepeviridae</td>\n</tr>\n<tr>\n<td>Envelope</td>\n<td>Non enveloped</td>\n<td>Enveloped</td>\n<td>Enveloped</td>\n<td>Envelope from HBV</td>\n<td>Quasi-enveloped</td>\n</tr>\n<tr>\n<td>Nuclear material</td>\n<td>ssRNA</td>\n<td>Partially dsDNA</td>\n<td>ssRNA</td>\n<td>Circular defective ssRNA</td>\n<td>ssRNA</td>\n</tr>\n<tr>\n<td>Antigens</td>\n<td>HAV Ag</td>\n<td>HBsAg, HBcAg, HBeAg, HBxAg</td>\n<td>HCV Ag</td>\n<td>HBsAg, HDAg</td>\n<td>HEV Ag</td>\n</tr>\n<tr>\n<td>Antibodies</td>\n<td>Anti-HAV Ab</td>\n<td>Anti-HBs Ab, Anti-HBc Ab, Anti-HBe Ab</td>\n<td>Anti-HCV Ab</td>\n<td>Anti-HBs Ab, Anti-HDV Ab</td>\n<td>Anti-HEV Ab</td>\n</tr>\n<tr>\n<td>Auto-antibodies</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>Anti-LKM 1</td>\n<td>Anti-LKM 3</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Routes of transmission</td>\n<td>Feco-oral, parenteral, sexual</td>\n<td>Perinatal, parenteral, sexual, percutaneous, direct mucosal contact</td>\n<td>Parenteral, perinatal, percutaneous, sexual</td>\n<td>Parenteral, sexual</td>\n<td>Feco-oral, zoonotic, vertical</td>\n</tr>\n<tr>\n<td>Incubation period</td>\n<td>30 days</td>\n<td>60 days</td>\n<td>50 days</td>\n<td>60 days</td>\n<td>40 days</td>\n</tr>\n<tr>\n<td>Chances of fulminant hepatic failure</td>\n<td>0.1%</td>\n<td>0.1 to 1%</td>\n<td>0.1%</td>\n<td>5% in coinfections and 20% in superinfections</td>\n<td>1-2% in adults and up to 25% in pregnant women</td>\n</tr>\n<tr>\n<td>Extrahepatic manifestations</td>\n<td>Rash, arthralgia</td>\n<td>Polyarteritis nodosa and membranous nephropathy</td>\n<td>Essential mixed cryoglobulinemia, MPGN, Metabolic syndrome</td>\n<td>&nbsp; &nbsp; &nbsp; -</td>\n<td>GBS, Bell&rsquo;s palsy, pancreatitis, &nbsp;and glomerulonephritis</td>\n</tr>\n<tr>\n<td>Resolution of acute infection</td>\n<td>2 months</td>\n<td>6 months</td>\n<td>6 months</td>\n<td>6 months</td>\n<td>3 months</td>\n</tr>\n<tr>\n<td>Progression to chronic infection</td>\n<td>No</td>\n<td>5-10%</td>\n<td>&gt;80%</td>\n<td>\n<p>10% of co-infections,</p>\n<p>90&ndash;100% of superinfections</p>\n</td>\n<td>\n<p>Only in immuno-compromised</p>\n</td>\n</tr>\n<tr>\n<td>HCC</td>\n<td>No</td>\n<td>May develop in chronic infections</td>\n<td>May develop in chronic infections</td>\n<td>May develop in chronic infections</td>\n<td>May develop in chronic infections</td>\n</tr>\n<tr>\n<td>Vaccine</td>\n<td>Available</td>\n<td>Available</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;-</td>\n<td>HBV vaccine</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; -</td>\n</tr>\n<tr>\n<td>Therapy</td>\n<td>None</td>\n<td>Entecavir, tenofovir, pegIFN-ùõÇ</td>\n<td>Velpatasvir, sofosbuvir, ribavirin</td>\n<td>PegIFN-ùõÇ</td>\n<td>None</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9137",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following is a new drug approved by the FDA for the treatment of Rett syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Olcegepant"
        },
        {
          "id": 2,
          "text": "Lasmiditan"
        },
        {
          "id": 3,
          "text": "Trofinetide"
        },
        {
          "id": 4,
          "text": "Erenumab"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><span><strong>Trofinetide</strong> is the newly <strong>FDA-approved drug</strong> for the treatment of <strong>Rett syndrome.</strong></span></p>\n<p><span>The mechanism by which trofinetide exerts therapeutic effects in patients with Rett syndrome is<strong> unknown</strong>. It is a synthetic analog of the amino‚Äêterminal tripeptide of insulin-like growth factor (IGF-1) designed to treat the core symptoms of Rett syndrome by <strong>potentially reducing neuroinflammation and supporting synaptic function of the protein fragment glypromate (GPE).&nbsp;</strong>IGF-1 is produced by both major types of brain cells &ndash; neurons and glia; IGF-1 in the brain is critical for both normal development and response to injury and disease<strong>.&nbsp;</strong>Trofinetide has been shown to <strong>inhibit the production of inflammatory cytokines,</strong> <strong>inhibit overactivation of microglia and astrocytes</strong>, and <strong>increase the amount of available IGF-1 </strong>that can bind to IGF-1 receptors.</span></p>\n<p><span>It is<strong>&nbsp;</strong>Indicated for the treatment of <strong>Rett syndrome.</strong></span></p>\n<p><span><strong>Adverse effects</strong> include diarrhea, vomiting, fever, seizure, anxiety, decreased appetite, fatigue, nasopharyngitis</span></p>\n<p>&nbsp;</p>\n<p><span>Other options:</span></p>\n<p><span>Option A:&nbsp;<strong>Olcegepant</strong>&nbsp;is a calcitonin gene-related peptide (<strong>CGRP</strong>)&nbsp;<strong>antagonist</strong> which was considered for the treatment of&nbsp;<strong>migraine,</strong>&nbsp;but discontinued.</span></p>\n<p><span>Option B:&nbsp;<strong>Lasmiditan</strong>&nbsp;is&nbsp;</span><span>a nontriptan 5HT1F receptor&ndash;selective agonist&nbsp;</span><span>and is used to treat migraine.</span></p>\n<p><span>Option D:&nbsp;<strong>Erenumab</strong> is a&nbsp;<strong>CGRP (calcitonin gene-related peptide) blocking antibody</strong>&nbsp;used in the treatment migraine.</span>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Note: The spelling of the drug in the options has been corrected from Trofin<strong data-stringify-type=\"bold\">i</strong>tide to Trofin<span><strong data-stringify-type=\"bold\">e</strong></span>tide.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9162",
      "difficulty": "medium"
    },
    {
      "text": "A 6-year-old boy was brought with a history of chronic cough, and foul-smelling stools. His sibling who had similar complaints died a few years back. Sweat chloride test and CFTR gene studies were done. CFTR gene codes for proteins involved in the transport of:",
      "choices": [
        {
          "id": 1,
          "text": "Na+"
        },
        {
          "id": 2,
          "text": "HCO3-"
        },
        {
          "id": 3,
          "text": "Cl-"
        },
        {
          "id": 4,
          "text": "K+"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario is suggestive of<strong>&nbsp;cystic fibrosis.&nbsp;</strong>In this condition, CFTR gene codes for proteins involved in the transport of Cl- ions.</p>\n<p><strong>Cystic fibrosis</strong> or <strong>mucoviscidosis</strong>&nbsp;is an <strong>autosomal recessive</strong> disorder with a mutation in the cystic fibrosis transmembrane regulator <strong>(CFTR) gene</strong> on <strong>chromosome 7q</strong>.&nbsp;The most common CFTR mutation is&nbsp;<strong>F508 deletion</strong>.</p>\n<p>CFTR gene encodes for <strong>ATP-gated chloride channels</strong> in the apical membranes of epithelial cells. It regulates the flow of ions across epithelial membranes of sweat glands, respiratory airways, pancreatic ducts, etc. The defect leads to high salt concentrations in sweat and viscous luminal secretions in the respiratory and gastrointestinal tracts.&nbsp;Excessive loss of salt in the sweat predisposes young children to <strong>salt-depletion</strong> episodes. Therefore, these children present with <strong>hypochloremic alkalosis</strong>, resulting in <strong>increased serum bicarbonate levels</strong>.&nbsp;</p><div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">Clinical manifestations/ complications of cystic fibrosis include:</div>\n</div>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<ul>\n<li><strong>Sinusitis</strong> and <strong>nasal polyps</strong></li>\n<li><strong>Respiratory </strong>- copious hyper-viscous and adherent pulmonary secretions with abnormal mucociliary clearance obstruct small and medium-sized airways leading to respiratory compromise. The disease can be further complicated by bronchiectasis and allergic bronchopulmonary aspergillosis (ABPA).</li>\n<li><strong>Gastrointestinal </strong>-<strong>&nbsp;</strong>\n<ul>\n<li>Thick and adherent exocrine secretions <strong>obstruct</strong> <strong>pancreatic</strong> <strong>ducts</strong> and impair the production and flow of digestive enzymes</li>\n<li>Tissue destruction of the <strong>exocrine</strong> <strong>pancreas</strong>, with fibrotic scarring, cyst proliferation, and loss of acinar tissue - fat malabsorption, steatorrhea, fat-soluble vitamin deficiencies</li>\n<li>Obstruction of intrahepatic bile ducts and parenchymal fibrosis leading to hepatic insufficiency and <strong>focal biliary cirrhosis</strong></li>\n<li><strong>Distal intestinal obstructive syndrome</strong> in <strong>adults</strong> and <strong>meconium ileus</strong> in <strong>neonates</strong></li>\n</ul>\n</li>\n<li><strong>Reproductive</strong>&nbsp;-<strong> males</strong> have&nbsp;<strong>infertility</strong> due to the congenital <strong>absence</strong> of bilateral <strong>vas</strong> <strong>deferens</strong> and defective sperm transport, resulting in&nbsp;<strong>obstructive azoospermia. Females</strong> have infertility due to abnormalities of the reproductive tract secretions.</li>\n</ul>\n<p>&nbsp;The&nbsp;<strong>diagnosis</strong>&nbsp;is&nbsp;<strong>confirmed</strong>&nbsp;if&nbsp;<strong>both</strong>&nbsp;of the following&nbsp;<strong>criteria</strong>&nbsp;are met:</p>\n</div>\n</div>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<ul>\n<li>Presence of\n<ul>\n<li><strong>Clinical symptoms</strong> affecting at least one organ system (respiratory, gastrointestinal, or genitourinary)&nbsp;<strong>or</strong></li>\n<li>Positive<strong> newborn screening</strong>&nbsp;<strong>or</strong></li>\n<li>A <strong>sibling</strong> with cystic fibrosis</li>\n</ul>\n</li>\n<li>Evidence of&nbsp;<strong>dysfunction</strong>&nbsp;of the&nbsp;<strong>CFTR gene</strong>&nbsp;by\n<ul>\n<li><strong>Two positive sweat chloride tes</strong>t results were obtained on separate days&nbsp;<strong>or</strong></li>\n<li>Identification of <strong>two CFTR mutations</strong> by genetic testing&nbsp;<strong>or</strong></li>\n<li>An <strong>abnormal</strong> measurement of <strong>nasal potential difference</strong></li>\n</ul>\n</li>\n</ul>\n<p>Cystic fibrosis requires a multidisciplinary approach to management. The correction of the defect can be via:</p>\n<ul>\n<li><strong>Lumacaftor,</strong> an FDA-approved drug that corrects the misfolding and reverts the Phe508del mutation defect</li>\n<li><strong>Ivacaftor</strong> potentiates CFTR channel opening and stimulates ion transport</li>\n</ul>\n<p>End-stage pulmonary failure requires <strong>lung transplantation</strong>.</p>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9141",
      "difficulty": "easy"
    },
    {
      "text": "The perinatal transmission of infection shows the spectrum of anemia, possibly myocarditis, high output cardiac failure, and ascites. Identify the causative agent.",
      "choices": [
        {
          "id": 1,
          "text": "Treponema pallidum"
        },
        {
          "id": 2,
          "text": "CMV"
        },
        {
          "id": 3,
          "text": "Parvovirus B19"
        },
        {
          "id": 4,
          "text": "Toxoplasma gondii"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical vignette with anemia, myocarditis, high output cardiac failure, ascites and the image showing hydrops fetalis point to a diagnosis of&nbsp;<strong>erythema infectiosum (Fifth disease) </strong>caused by<strong> parvovirus B19.</strong></p>\n<p>Parvovirus B19 infects fetal erythroid progenitor cells and causes <strong>anemia</strong>. Severe anemia leads to&nbsp;<strong>high-output cardiac failure</strong>&nbsp;and&nbsp;<strong>hydrops fetalis.&nbsp;</strong>In addition to bone marrow, the liver is also affected causing <strong>ascites</strong>, because it is involved in erythropoiesis in the early fetal life.&nbsp;</p>\n<p>Erythema infectiosum presents as a prodrome of low-grade fever, headache, and a mild upper respiratory tract infection after an incubation period of 4-28 days. A characteristic rash occurs in 3 stages:</p>\n<ul>\n<li>Erythematous facial flushing causing a slapped cheek appearance in the 1st stage</li>\n<li>Diffuse macular erythema spreads to the trunk and proximal extremities in the 2nd stage.</li>\n<li>Central clearing of the macular lesions, giving the rash a lacy, reticulated appearance in the 3rd stage.</li>\n</ul>\n<p>The rash is more prominent on extensor surfaces and spares the palms and soles. At this stage, affected children are afebrile and do not appear ill.&nbsp; Children with erythema infectiosum are not likely to be infectious at presentation.</p>\n<p>Complications of the disease include:</p>\n<ul>\n<li>Arthralgias or arthritis</li>\n<li><strong>Transient Aplastic Crisis</strong>: A transient arrest of erythropoiesis and absolute reticulocytopenia in serum hemoglobin in individuals with chronic hemolytic conditions like sickle cell anemia</li>\n<li>Thrombocytopenic purpura</li>\n<li><strong>Myocarditis</strong></li>\n<li>A papular-purpuric &ldquo;gloves-and-socks&rdquo; syndrome&nbsp;</li>\n<li>Neurological: Aseptic meningitis, encephalitis, and peripheral neuropathy, stroke in children with sickle cell disease&nbsp;</li>\n<li>Infection-associated hemophagocytic syndrome in immunocompromised patients</li>\n<li>Maternal infection is associated with <strong>nonimmune fetal hydrops</strong> and intrauterine fetal demise</li>\n</ul>\n<p>There is no data to support the use of IVIG for postexposure prophylaxis, however, it has been used with some success to treat B19-related episodes of anemia and bone marrow failure in immunocompromised children. There is no specific antiviral therapy for B19 infection.</p><hr><h3>Related Pearl: Viral infections associated with rash</h3><table>\n<tbody>\n<tr>\n<td><strong>Viral infection&nbsp;</strong></td>\n<td><strong>Rash characteristics&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Chickenpox</td>\n<td>Appears 1st&nbsp;day of fever, <strong>centripetal</strong>, pleomorphic, <strong>dewdrops on rose petal</strong> appearance</td>\n</tr>\n<tr>\n<td>Measles</td>\n<td>Appears on the 4th&nbsp;day over the face and <strong>retroauricular</strong> origin</td>\n</tr>\n<tr>\n<td>Rubella</td>\n<td>Rash on day 1 over the face</td>\n</tr>\n<tr>\n<td>\n<p>Erythema infectiosum</p>\n</td>\n<td>Rash on&nbsp;cheeks (<strong>slapped&nbsp;cheek</strong> appearance), moves to trunk and extremities</td>\n</tr>\n<tr>\n<td>Exanthem&nbsp;subitum</td>\n<td>Macules&nbsp;or maculopapular rash</td>\n</tr>\n<tr>\n<td>Infectious mononucleosis</td>\n<td>Associated with maculopapular rash</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/ee3ff99aad3645fb8b7287f34751f4af.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9155",
      "difficulty": "easy"
    },
    {
      "text": "In which of the following conditions is live vaccination not contraindicated?<div class='question-desc-html'><ol class=\"ul1\">\n<li class=\"li1\">DiGeorge syndrome</li>\n<li class=\"li1\">Wiskott Aldrich Syndrome</li>\n<li class=\"li1\">Ataxia telengiectasia</li>\n<li class=\"li1\">Complement deficiency</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "4 only"
        },
        {
          "id": 2,
          "text": "1 only"
        },
        {
          "id": 3,
          "text": "1 and 3 "
        },
        {
          "id": 4,
          "text": "2 and 3 "
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p class=\"p1\">Live vaccination is not contraindicated in <strong>complement deficiency</strong>. In DiGeorge syndrome, Wiskott-Aldrich Syndrome, and Ataxia telangiectasia, live vaccines are contraindicated.&nbsp;</p>\n<p>In patients with DiGeorge syndrome, Wiskott-Aldrich Syndrome, and Ataxia telangiectasia, there is a risk of severe or fatal infections due to live vaccines because of their impaired T-cell immunity. In contrast, a patient with a complement deficiency has an intact T-cell and B-cell immunity, which are crucial for building an immune response against live vaccines. These patients have an increased susceptibility to certain bacterial infections, especially those caused by Neisseria species, due to defects in the complement system, which is part of the innate immune system. But their adaptive immune system, which is primarily responsible for responding to vaccinations, is generally intact. Therefore, live vaccinations are not typically contraindicated in these patients.</p>\n<p class=\"p1\"><strong>DiGeorge syndrome</strong> is due to a&nbsp;<strong>developmental defect </strong>involving the endodermal derivatives of the<strong> 3<sup>rd</sup></strong> and<strong> 4<sup>th</sup> pharyngeal pouches.&nbsp;</strong>Cell-mediated immunity is defective due to<strong> decreased T-cells</strong>. Affected individuals also have depressed graft rejection, hypocalcemia, and cardiac defects.&nbsp;For <strong>severe T cell deficiencies</strong>&nbsp;(e.g. severe combined immunodeficiency disease [SCID], complete DiGeorge syndrome), no live viral or live bacterial vaccines should be given.</p>\n<p class=\"p1\"><strong>Wiskott-Aldrich syndrome(WAS)</strong> is&nbsp;<strong>an X-linked recessive</strong>&nbsp;immunodeficiency disorder. It is caused by mutations in the Wiskott-Aldrich syndrome protein (<strong>WASp</strong>) that primarily affects the&nbsp;<strong>T lymphocytes</strong>.&nbsp;In patients with <strong>partial T cell deficiencies</strong> (e.g., partial DiGeorge syndrome, Wiskott-Aldrich syndrome),&nbsp;all live viral vaccines are avoided.</p>\n<p class=\"p1\"><strong>Ataxia telangiectasia</strong> is caused due to mutation of the <strong>ATM gene</strong>. This gene is involved in the&nbsp;<strong>repair</strong>&nbsp;of&nbsp;<strong>double-strand DNA breaks.</strong>&nbsp;This defect in DNA repair leads to impaired Ig isotype switching and the formation of antigen receptors. As a result, the patient is immunodeficient with <strong>partial T cell deficiency, </strong>and hence live vaccines are avoided.&nbsp;</p><hr><h3>Related Pearl: Clinical features of DiGeorge syndrome- Mnemonic</h3><p><strong>DiGeorge</strong> <strong>syndrome</strong>&nbsp;is a cellular immunodeficiency disorder caused by the deletion of a small segment of <strong>chromosome 22 (22q11)&nbsp;</strong>leading to a developmental defect involving the endodermal derivatives of the <strong>third and fourth pharyngeal pouches</strong>.&nbsp;(Thymus and parathyroid glands)</p>\n<p>The clinical features can be remembered with the <strong>mnemonic</strong> &ndash; <strong>CATCH</strong></p>\n<ul>\n<li><strong>C &ndash; C</strong>ardiac defects</li>\n<li><strong>A &ndash; A</strong>bnormal facies</li>\n<li><strong>T &ndash; T</strong>hymic aplasia</li>\n<li><strong>C &ndash; C</strong>left palate</li>\n<li><strong>H &ndash; H</strong>ypocalcemia</li>\n</ul>\n<p>The image below shows the abnormal facies in DiGeorge syndrome.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5b6e236b65034a479699ad3df12785ffx720x731.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9165",
      "difficulty": "medium"
    },
    {
      "text": "Nada's Minor Criteria includes: <div class='question-desc-html'><ol>\n<li>Systolic mumur Grade 3</li>\n<li>Diastolic murmur</li>\n<li>Abnormal second heart sound</li>\n<li>Abnormal BP</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "3 and 4 "
        },
        {
          "id": 2,
          "text": "1, 2 and 3"
        },
        {
          "id": 3,
          "text": "1, 2, 3 and 4"
        },
        {
          "id": 4,
          "text": "2, 3 and 4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Nada's Minor Criteria </strong>includes<strong> abnormal second heart sound</strong> and <strong>abnormal BP. </strong></p>\n<p>Nada&rsquo;s criteria is used to diagnose<strong> congenital heart disease</strong> in children.&nbsp;The presence of <strong>1 major</strong> or <strong>2 minor</strong> criteria indicates congenital heart disease.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Major criteria&nbsp;</strong></td>\n<td><strong>Minor criteria</strong></td>\n</tr>\n<tr>\n<td>Systolic murmur&nbsp; grade 3 or more</td>\n<td>Systolic murmur &lt; grade 3</td>\n</tr>\n<tr>\n<td>Any diastolic murmur</td>\n<td>Abnormal second sound (S2)</td>\n</tr>\n<tr>\n<td>Cyanosis</td>\n<td>Abnormal ECG</td>\n</tr>\n<tr>\n<td>Congestive cardiac failure</td>\n<td>\n<p>Abnormal chest X-ray findings</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p>Abnormal BP</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9116",
      "difficulty": "medium"
    },
    {
      "text": "An 18-month-old child with a 3-day history of watery diarrhea and vomiting presented with altered sensorium. Which of the following are differential diagnoses?<div class='question-desc-html'><ol>\n<li>Severe dehydration</li>\n<li>HUS</li>\n<li>Cerebral Venous Thrombosis</li>\n<li>Hyponatremia</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2, 3, 4"
        },
        {
          "id": 2,
          "text": "1, 2, 3"
        },
        {
          "id": 3,
          "text": "1, 3, 4"
        },
        {
          "id": 4,
          "text": "2, 3, 4"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The differential diagnoses in a child with a history of watery diarrhea and altered sensorium include <strong>severe dehydration</strong>, <strong>cerebral venous thrombosis, </strong>and <strong>hyponatremia.&nbsp;</strong></p>\n<p>The lack of dysentery(bloody diarrhoea) and the short period of interval between diarrhoeal episodes and the symptom complex, help to rule out&nbsp;<strong>Haemolytic Uremic Syndrome (HUS). </strong>HUS is a form of&nbsp;<strong>microangiopathic hemolytic anemia</strong>&nbsp;usually occurring in children <strong>less than 5 years</strong> of age. There are 2 forms of HUS:</p>\n<ol>\n<li><strong>Typical HUS</strong>&nbsp;which is usually followed by a gastrointestinal infection most commonly by E.coli. The infection in turn affects the gastric mucosa and alters the endothelial cells which promotes platelet activation and aggravation.</li>\n<li><strong>Atypical HUS</strong>&nbsp;which occurs due to deficiency in certain proteins like complement factor H, factor I, or CD46.&nbsp;</li>\n</ol>\n<p>Clinical features of the condition include&nbsp;<strong>bloody diarrhea </strong>which occurs<strong>&nbsp;5-10 days</strong> before the onset of hemolytic uremic syndrome<strong>, abdominal pain, fatigue, cramping, </strong>and<strong> vomiting.&nbsp;</strong>The most dangerous complication is<strong>&nbsp;renal failure requiring dialysis </strong>or <strong>renal transplantation.&nbsp;</strong>Treatment is mainly supportive and the nature of the illness is usually self-limiting.&nbsp;</p>\n<p>Differential diagnoses in a child presenting with <strong>altered sensorium/ seizures</strong> with <strong>diarrhea</strong>:</p>\n<ul>\n<li>Hypo- or hypernatremia</li>\n<li>Hypoglycemia</li>\n<li>Encephalitis or meningitis</li>\n<li>Febrile seizures</li>\n<li>Cerebral or saggital sinus thrombosis</li>\n</ul><hr><h3>Related Pearl: Symptoms associated with different levels of dehydration</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Symptoms</strong></span></td>\n<td><span><strong>No or minimal dehydration</strong></span></td>\n<td><span><strong>Mild to moderate dehydration</strong></span></td>\n<td><span><strong>Severe dehydration</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Loss of body weight</strong></span></td>\n<td><span>&lt;3%</span></td>\n<td><span>3&ndash;9%</span></td>\n<td><span>&gt;9%</span></td>\n</tr>\n<tr>\n<td><span><strong>Mental status</strong></span></td>\n<td><span>Well; <strong>alert</strong></span></td>\n<td><span>Fatigued or&nbsp;<strong>irritable</strong></span></td>\n<td><span><strong>Lethargic </strong>or unconscious</span></td>\n</tr>\n<tr>\n<td><span><strong>Thirst</strong></span></td>\n<td><span>Drinks normally</span></td>\n<td><span><strong>Thirsty</strong>; eager to drink</span></td>\n<td><span>Drinks poorly</span></td>\n</tr>\n<tr>\n<td><span><strong>Heart rate</strong></span></td>\n<td><span>Normal</span></td>\n<td><span>Normal to increased</span></td>\n<td><span>Tachycardia</span></td>\n</tr>\n<tr>\n<td><span><strong>Quality of pulse</strong></span></td>\n<td><span>Normal</span></td>\n<td><span>Normal to decreased</span></td>\n<td><span>Weak, thready or impalpable</span></td>\n</tr>\n<tr>\n<td><span><strong>Skin turgor test</strong></span></td>\n<td><span>Instant recoil</span></td>\n<td><span><strong>Recoil in &lt;2</strong> <strong>sec</strong></span></td>\n<td><span>Recoil in &gt;2 sec</span></td>\n</tr>\n<tr>\n<td><span><strong>Capillary refill</strong></span></td>\n<td><span>Normal</span></td>\n<td><span>Prolonged</span></td>\n<td><span>Prolonged</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Treatment of dehydration based on severity</h3><p><strong>Plan A</strong>: For no dehydration or minimal dehydration.&nbsp;ORS is administered after each loose stool.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Amount&nbsp;</strong></td>\n</tr>\n<tr>\n<td>&lt;2 years</td>\n<td>50&ndash;100 mL</td>\n</tr>\n<tr>\n<td>2-10 years</td>\n<td>100&ndash;200 mL</td>\n</tr>\n<tr>\n<td>&gt;10 years</td>\n<td>As much fluid as they want</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Plan B</strong>: For moderate dehydration.</p>\n<p>The amount of oral rehydration solution (ORS) to be given is <strong>75 mL/kg body weight</strong> (wt &times; 75).</p>\n<p><strong>Plan C</strong>: Severe dehydration</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td>First, give<strong> 30 mL/kg in</strong></td>\n<td>Followed by <strong>70 mL/kg in</strong></td>\n<td>Total<strong> 100 mL/kg in</strong></td>\n</tr>\n<tr>\n<td>Infants (under 12 months)</td>\n<td>1 hr</td>\n<td>5 hrs</td>\n<td>&nbsp;6 hrs</td>\n</tr>\n<tr>\n<td>Older</td>\n<td>30 min</td>\n<td>2&frac12; hrs</td>\n<td>&nbsp;3 hrs</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Note:&nbsp;</strong><strong>Ringer lactate</strong> (ideal) or normal saline is used as intravenous fluids.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9118",
      "difficulty": "medium"
    },
    {
      "text": "The causative agent of this condition is associated with which of the following conditions?",
      "choices": [
        {
          "id": 1,
          "text": "Gingivostomatitis"
        },
        {
          "id": 2,
          "text": "Pure red cell aplasia"
        },
        {
          "id": 3,
          "text": "Molluscum contagiosum"
        },
        {
          "id": 4,
          "text": "Kaposi sarcoma"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><span data-preserver-spaces=\"true\">The given image showing the classical <strong>slapped cheek appearance</strong> is strongly suggestive of <strong>erythema infectiosum</strong>.&nbsp;It is caused&nbsp;by&nbsp;<strong>Parvovirus. </strong></span><span data-preserver-spaces=\"true\"><strong>Parvovirus B19</strong> is associated with <strong>p</strong><strong>ure red cell aplasia</strong>.&nbsp;</span></p>\n<p><span data-preserver-spaces=\"true\">Clinically, parvovirus B-19 infection may have several presentations-</span></p>\n<ul>\n<li><span data-preserver-spaces=\"true\">Erythema infectiosum- Also known as the<strong> fifth disease.</strong> The incubation period after infection is typically around 1-2 weeks.&nbsp;</span>The hallmark of erythema infectiosum is the&nbsp;characteristic rash, which appears initially as&nbsp;erythematous facial flushing, often described as a&nbsp;&ldquo;<strong>slapped cheek</strong>&rdquo; appearance. Later the rash spreads rapidly or concurrently to the&nbsp;trunk and proximal extremities as diffuse macular erythema. The child may be febrile.&nbsp;</li>\n<li><strong>Transient aplastic crisis</strong>- It may be seen in patients with underlying&nbsp;<strong>chronic hemolytic anemia</strong>&nbsp;like sickle-cell disease, thalassemia, hereditary spherocytosis, and RBC enzyme deficiencies like pyruvate kinase deficiency.&nbsp;Patients with aplastic crisis appear ill with fever, malaise, and pale with tachycardia and tachypnea due to profound anemia. The rash may or may not be present.&nbsp;</li>\n<li><strong>Pure red cell aplasia</strong>- Erythrocyte <strong>P blood group antigen</strong> is the primary cell receptor for the virus. Persistent Parvovirus B19 infection in immunocompromised patients can cause chronic suppression of bone marrow and chronic anemia leading to pure red cell aplasia.&nbsp;</li>\n<li>Maternal infection is associated with<strong> non-immune fetal hydrops</strong> and intrauterine fetal demise.</li>\n<li>Only about 7% of children with erythema infectiosum have, whereas <strong>80% of adults</strong>&nbsp;have&nbsp;<strong>joint involvement.</strong></li>\n<li>Infection-associated <strong>hemophagocytic syndrome</strong> in immunocompromised patients.</li>\n</ul>\n<p>The diagnosis of erythema infectiosum is made clinically and does not require investigations routinely. Detection of viral DNA in the blood by PCR or&nbsp;nucleic acid hybridization may be done for immunocompromised cases or for prenatal diagnosis of infection.</p>\n<p>It is self-limited and resolves on its own. IVIG may be given to immunocompromised children.</p><hr><h3>Related Pearl: Viral infections associated with rash</h3><table>\n<tbody>\n<tr>\n<td><strong>Viral infection&nbsp;</strong></td>\n<td><strong>Rash characteristics&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Chickenpox</td>\n<td>Appears 1st&nbsp;day of fever, <strong>centripetal</strong>, pleomorphic, <strong>dewdrops on rose petal</strong> appearance</td>\n</tr>\n<tr>\n<td>Measles</td>\n<td>Appears on the 4th&nbsp;day over the face and <strong>retroauricular</strong> origin</td>\n</tr>\n<tr>\n<td>Rubella</td>\n<td>Rash on day 1 over the face</td>\n</tr>\n<tr>\n<td>\n<p>Erythema infectiosum</p>\n</td>\n<td>Rash on&nbsp;cheeks (<strong>slapped&nbsp;cheek</strong> appearance), moves to trunk and extremities</td>\n</tr>\n<tr>\n<td>Exanthem&nbsp;subitum</td>\n<td>Macules&nbsp;or maculopapular rash</td>\n</tr>\n<tr>\n<td>Infectious mononucleosis</td>\n<td>Associated with maculopapular rash</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Skin rashes: 1st to 6th diseases</h3><table>\n<tbody>\n<tr>\n<td>\n<p>1<sup>st</sup> disease</p>\n</td>\n<td>\n<p>Measles</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2<sup>nd</sup> disease</p>\n</td>\n<td>\n<p>Scarlet fever</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3<sup>rd</sup> disease</p>\n</td>\n<td>\n<p>Rubella</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>4<sup>th</sup> disease</p>\n</td>\n<td>\n<p>Duke&rsquo;s disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>5<sup>th</sup> disease</p>\n</td>\n<td>\n<p>Erythema infectiosum</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>6<sup>th</sup> disease</p>\n</td>\n<td>\n<p>Roseola infantum</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f62e23303e5348a7aa37c3f98f8400ac.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9129",
      "difficulty": "easy"
    },
    {
      "text": "A 4-year-old boy presented with a history of fever, conjunctival congestion, and erythematous desquamation of the skin as shown in the images below. A 2D echo shows a coronary aneurysm. What is the first line of treatment for his condition?",
      "choices": [
        {
          "id": 1,
          "text": "Aspirin"
        },
        {
          "id": 2,
          "text": "IVIG"
        },
        {
          "id": 3,
          "text": "Clopidogrel"
        },
        {
          "id": 4,
          "text": "LMWH"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>This child¬†with a history of fever, conjunctival congestion, strawberry tongue, and¬†erythematous desquamation of the skin is likely to have <strong>Kawasaki's disease. </strong>The first line of treatment in Kawasaki disease is<strong> IVIG (intravenous immunoglobulin).</strong></p>\n<p>Kawasaki's disease is also known as <strong>mucocutaneous lymph node syndrome</strong>. It is a vasculitis condition of unknown etiology.¬† Clinical features include a <strong>high spiking fever</strong> that is <strong>unresponsive </strong>to<strong> antipyretics</strong>. The fever can last between 5 days to 3-4 weeks.¬†The five principal clinical criteria for Kawasaki's disease are:¬†</p>\n<ul>\n<li>Bilateral <strong>nonexudative conjunctival infection</strong>¬†with limbal sparing</li>\n<li>Erythema of the oral and pharyngeal mucosa, <strong>strawberry tongue</strong>, and red, cracked lips</li>\n<li><strong>Edema </strong>and<strong> erythema </strong>of the<strong> hands</strong> and feet</li>\n<li>Various forms of <strong>rash-¬†</strong>maculopapular, erythema multiforme, scarlatiniform</li>\n<li>Nonsuppurative <strong>cervical lymphadenopathy</strong></li>\n</ul>\n<p>Diagnosis requires <strong>fever</strong>¬†and <strong>at least four</strong> of the five <strong>principal criteria</strong>.¬†<strong>Myocarditis</strong> develops frequently in acute Kawasaki disease. It presents as tachycardia and reduced ventricular systolic function. The tachycardia will be disproportionate to the fever. Patients may develop <strong>coronary artery aneurysms</strong> in the 2nd to 3rd week of illness. They are generally asymptomatic and diagnosed on echocardiography. However, if large it can lead to death. Thus, <strong>echocardiography </strong>should be performed <strong>at diagnosis</strong> and <strong>after 1-2 weeks</strong>.¬†</p>\n<p>Other symptoms include periungual desquamation,<strong>¬†</strong>gastrointestinal symptoms (vomiting, abdominal pain, diarrhea), cough, rhinorrhea, and arthritis. Laboratory evaluation will reveal elevated leukocytes, platelets, erythrocyte sedimentation rate, and C-reactive protein levels.¬†</p>\n<p>Treatment involves <strong>2g/kg of intravenous immunoglobulin</strong> as an infusion over 10-12 hours within 10 days of onset. Moderate to high-dose <strong>aspirin</strong> should be administered until the patient is afebrile.¬†</p>\n<p><!-- --></p><hr><h3>Related Pearl: Kawasaki disease criteria</h3><p><strong>Diagnostic criteria of Kawasaki disease</strong>:¬†</p>\n<p><strong>Fever of five days or more</strong> duration <strong>plus four</strong> <strong>out of the following</strong> five criteria:</p>\n<ol>\n<li>Oropharyngeal changes (90% of cases)</li>\n<li>Changes in peripheral extremities (90% of cases)</li>\n<li>Cervical lymphadenopathy (~75% of cases)</li>\n<li>Polymorphous rash (95% of cases)</li>\n<li>Bilateral non-purulent conjunctival infection (90% of cases)</li>\n</ol>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/69d5ad270aca4dae8f37cad3c84fa902.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9147",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not associated with Down's syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Conductive hearing loss"
        },
        {
          "id": 2,
          "text": "Short stature"
        },
        {
          "id": 3,
          "text": "Hypothyroidism"
        },
        {
          "id": 4,
          "text": "Caudal regression"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Among the choices provided,<strong>¬†Caudal regression</strong> is <strong>not¬†associated</strong> with Down‚Äôs syndrome. It occurs more frequently in <strong>infants</strong>¬†of¬†<strong>diabetic mothers</strong>¬†(both¬†<strong>preconceptionally</strong>¬†and early in¬†<strong>pregnancy)</strong>¬†than in other infants although the exact mechanism is unclear.¬†</p>\n<p>Down‚Äôs syndrome is an¬†<strong>autosomal disorder</strong>. It was described by Langdon Down in 1866. It is also called¬†<strong>trisomy 21 or mongolism.¬†</strong>The clinical features of Down's syndrome seen in older children are:</p>\n<ul>\n<li><strong>Short stature</strong></li>\n<li>Small round head</li>\n<li>Narrow tilted eye slits</li>\n<li>Mal-formed ears</li>\n<li>Short broad hands</li>\n<li>Lax limbs</li>\n<li>Mental retardation</li>\n</ul>\n<p>Conditions most commonly associated with Down‚Äôs syndrome:</p>\n<ul>\n<li>Congenital heart disease (in about 35% of cases)</li>\n<li>Gastrointestinal anomalies (in about 10%)</li>\n<li>Chronic serous otitis media (in &gt;50%)</li>\n<li><strong>Conductive hearing loss</strong></li>\n<li><strong>Hypothyroidism</strong></li>\n<li>Alzheimer‚Äôs disease (in the 30's and 40‚Äôs)</li>\n<li>Epilepsy (in about 10%)</li>\n<li>Ocular disorders</li>\n<li>Reduced fertility</li>\n<li>Reduced life span (Often due to complications like infections)</li>\n</ul>\n<p>The frequency of Down's syndrome increases with rising maternal age. The risk of a woman who is 20 is 1 in 3000 but that of a woman who is 45 is 1 in 50.</p>\n<p>It seems to be unaffected by the age of the father.</p>\n<p><strong>Note: Genetic counseling</strong>: It can either be¬†<strong>prospective</strong>¬†or¬†<strong>retrospective</strong>. Prospective genetic counseling refers to the prevention of disease by the prevention or reduction of heterozygous marriage like in sickle cell anemia or thalassemia. Retrospective genetic counseling means that the hereditary disorder has already occurred in the family and methods like contraception, pregnancy termination or sterilization are to be used to avoid any serious health disorder in the unborn baby.¬†</p>\n<p>Methods of early diagnosis and treatment are early detection of genetic carriers, prenatal diagnosis, screening of newborn infants, and recognizing pre-clinical cases.</p><hr><h3>Related Pearl: Prenatal screening for Down‚Äôs syndrome</h3><ul>\n<li><strong>USG findings</strong>\n<ul>\n<li>Intrauterine growth retardation (so decreased blood flow)</li>\n<li>Choroid plexus cysts</li>\n<li>Increased <strong>nuchal translucency &gt;3 mm</strong></li>\n<li>Hypoplastic nasal bone</li>\n<li>Congenital heart defects</li>\n<li>Increased intestinal echogenicity</li>\n<li>Duodenal atresia</li>\n</ul>\n</li>\n<li><strong>Maternal serum markers</strong>\n<ul>\n<li>Decreased: Alpha-fetoprotein (AFP), unconjugated estriol, pregnancy-associated plasma protein-A (PAPP-A)</li>\n<li>Increased: Human chorionic gonadotrophin (HCG), inhibin, neutrophil alkaline phosphatase</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Amniocentesis</strong>: 14<sup>th</sup>-18<sup>th</sup> week of pregnancy</li>\n<li><strong>Chorionic villus sampling</strong>\n<ul>\n<li>10<sup>th</sup> to 12<sup>th</sup> week of pregnancy: Gives the&nbsp;diagnosis in the&nbsp;first trimester</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1229",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is correct about congenital CMV?",
      "choices": [
        {
          "id": 1,
          "text": "40-50 % of the cases are symptomatic at birth"
        },
        {
          "id": 2,
          "text": "Optimum sample for PCR is blood/ urine/ saliva sample within 2-3 weeks of birth"
        },
        {
          "id": 3,
          "text": "If asymptomatic at birth, then there is a higher risk of developing SNHL later"
        },
        {
          "id": 4,
          "text": "Most common congenital infection after congenital syphilis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The correct statement regarding CMV infection is <strong>optimum sample </strong>for <strong>PCR</strong> is blood/ urine/ saliva <strong>sample within 2-3 weeks </strong>of birth</p>\n<p>CMV is the <strong>most common congenital infection </strong>(Option D). The clinical manifestations are <strong>hepatosplenomegaly, petechial rashes, jaundice</strong>, <strong>chorioretinitis,</strong> and <strong>microcephaly.</strong> One of the <strong>long-term sequelae</strong> is <strong>sensorineural hearing loss</strong>.¬†Neuroimaging shows <strong>intracranial periventricular calcifications.</strong> Other manifestations include IUGR, hydrops, microcephaly, pneumonitis, chorioretinitis, seizures, abnormal dentition, and hypocalcified enamel.¬†</p>\n<p>Only <strong>10% </strong>of the infected babies are <strong>symptomatic </strong>(Option A). <strong>Asymptomatic</strong> neonates have <strong>lesser</strong> chances of having late <strong>sequelae</strong> i.e. sensorineural hearing loss. About half of the symptomatic infants develop long-term sequelae which include sensorineural hearing loss (SNHL), vision loss, seizure disorders, mental retardation, and developmental delay. However, in <strong>asymptomatic</strong> infants, only about <strong>13.5% </strong>develop long-term sequelae which is commonly<strong> SNHL</strong> (option C).</p>\n<p>Diagnosis can be made by the presence of <strong>IgM antibodies</strong> in the fetal blood. Isolation of the virus from the <strong>urine</strong> or <strong>blood </strong>by <strong>PCR </strong>is more sensitive. The investigation of choice is <strong>PCR</strong> or <strong>viral culture</strong>. It should be done <strong>within the first three weeks of life</strong>. After this period, it is difficult to distinguish between a congenital and an acquired infection. Since not all affected infants are viremic at birth, <strong>urine</strong> and/or <strong>saliva</strong> are <strong>more reliable samples </strong>than blood (Option B).</p>\n<p>There is no definitive treatment for congenital CMV infection. Treatment with <strong>ganciclovir</strong> is indicated only in patients with progressive neurologic disease and deafness. Below is the image showing the <strong>blueberry muffin baby.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8190e65c717840348c7b48bad4f5ed3ex237x212.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1226",
      "difficulty": "medium"
    },
    {
      "text": "A 3.5 kg term neonate born to a mother with eclampsia, did not cry at birth. Which of the following is the criteria for perinatal asphyxia?",
      "choices": [
        {
          "id": 1,
          "text": "APGAR persists at 4-7 for > 5 minutes"
        },
        {
          "id": 2,
          "text": "Cord pH < 7.2"
        },
        {
          "id": 3,
          "text": "Hypocalcemia"
        },
        {
          "id": 4,
          "text": "Hypotonia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<div class=\"page\" title=\"Page 175\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 175\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Among the given options, the¬†<strong>essential criterion</strong> for <strong>perinatal asphyxia</strong>¬†is¬†<strong>hypotonia.</strong></p>\n<p><strong>Perinatal asphyxia </strong>is an insult to the fetus or newborn due to a lack of oxygen <strong>(hypoxia)</strong> and/or a lack of perfusion<strong> (ischemia)</strong> to the various organs. It is often associated with <strong>tissue lactic acidosis</strong> and<strong> hypercarbia.</strong></p>\n<p><strong>Essential criteria</strong> for perinatal asphyxia:</p>\n</div>\n</div>\n</div>\n<ul>\n<li>Umbilical arterial blood sample indicating prolonged metabolic or mixed acidemia <strong>(pH &lt; 7.O).</strong></li>\n<li><strong>Apgar score of 0-3</strong>¬†persisting for<strong> &gt;5 minutes.</strong></li>\n<li>Neurological manifestations appearing in the immediate neonatal period Ex:-¬†seizures, coma,<strong> hypotonia,</strong> or hypoxic ischemic encephalopathy (HIE).</li>\n<li>Neonatal¬†<strong>multiorgan dysfunction.</strong></li>\n</ul>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1446",
      "difficulty": "hard"
    },
    {
      "text": "Choose the correct statements for cystic fibrosis:<div class='question-desc-html'><p>¬† ¬† ¬† ¬† ¬† ¬†i. Increased Cl- in sweat.</p>\n<p>¬† ¬† ¬† ¬† ¬† ¬†ii. Decreased Cl- in sweat.</p>\n<p>¬† ¬† ¬† ¬† ¬† ¬†iii. Increased Cl- in pancreatic juice.</p>\n<p>¬† ¬† ¬† ¬† ¬† ¬†iv. Decreased Cl- in pancreatic juice.<br /><br /></p></div>",
      "choices": [
        {
          "id": 1,
          "text": "i and iii"
        },
        {
          "id": 2,
          "text": "ii and iii"
        },
        {
          "id": 3,
          "text": "i and iv"
        },
        {
          "id": 4,
          "text": "ii and iv"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll answer-html ng-star-inserted\">\n<p>In<strong> cystic fibrosis, </strong>there are<strong> increased chloride levels </strong>in <strong>sweat </strong>and<strong> decreased Chloride levels</strong> in <strong>pancreatic juice.¬†</strong>The¬†chloride level of sweat,¬†known as the <strong>sweat test</strong>, is used to diagnose¬†<strong>cystic fibrosis</strong>¬†(CF). A sweat chloride level of <strong>&gt;60 mmol/L</strong> is <strong>diagnostic</strong> of CF.</p>\n<p><strong>Cystic fibrosis</strong>¬†or¬†<strong>mucoviscidosis</strong>¬†is an¬†<strong>autosomal recessive</strong>¬†disorder with a mutation in the cystic fibrosis transmembrane regulator¬†<strong>(CFTR) gene</strong>¬†on¬†<strong>chromosome 7q</strong>.¬†The most common CFTR mutation is¬†<strong>F508 deletion</strong>.¬†</p>\n<p>CFTR gene encodes for¬†<strong>ATP-gated chloride channels</strong>¬†in the apical membranes of epithelial cells. The function of the CFTR gene on chloride channels is organ-specific. In <strong>sweat glands</strong>, the <strong>normal function</strong> of the CFTR gene is to <strong>reabsorb chloride</strong> ions. But in the <strong>pancreatic ducts</strong> and <strong>respiratory airways</strong>, the <strong>normal function</strong> of the CFTR gene is to <strong>secrete chloride</strong> ions. So, in cystic fibrosis, due to defect in the chloride channels, chloride levels in the sweat increase, and chloride levels in the pancreatic juices decreases. Excessive loss of salt in the sweat predisposes young children to¬†<strong>salt-depletion</strong>¬†episodes. Therefore, these children present with¬†<strong>hypochloremic alkalosis</strong>, resulting in¬†<strong>increased serum bicarbonate levels</strong>.¬†</p>\n</div>\n</div>\n<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll answer-html ng-star-inserted\">\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">Clinical manifestations/ complications of cystic fibrosis include:</div>\n</div>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<ul>\n<li><strong>Sinusitis</strong>¬†and¬†<strong>nasal polyps</strong></li>\n<li><strong>Respiratory¬†</strong>- copious hyper-viscous and adherent pulmonary secretions with abnormal mucociliary clearance obstruct small and medium-sized airways leading to respiratory compromise. The disease can be further complicated by bronchiectasis and allergic bronchopulmonary aspergillosis (ABPA).</li>\n<li><strong>Gastrointestinal¬†</strong>-<strong>¬†</strong>\n<ul>\n<li>Thick and adherent exocrine secretions¬†<strong>obstruct</strong>¬†<strong>pancreatic</strong>¬†<strong>ducts</strong>¬†and impair the production and flow of digestive enzymes</li>\n<li>Tissue destruction of the¬†<strong>exocrine</strong>¬†<strong>pancreas</strong>, with fibrotic scarring, cyst proliferation, and loss of acinar tissue - fat malabsorption, steatorrhea, fat-soluble vitamin deficiencies</li>\n<li>Obstruction of intrahepatic bile ducts and parenchymal fibrosis leading to hepatic insufficiency and¬†<strong>focal biliary cirrhosis</strong></li>\n<li><strong>Distal intestinal obstructive syndrome</strong>¬†in¬†<strong>adults</strong>¬†and¬†<strong>meconium ileus</strong>¬†in¬†<strong>neonates</strong></li>\n</ul>\n</li>\n<li><strong>Reproductive</strong>¬†-<strong>¬†males</strong>¬†have¬†<strong>infertility</strong>¬†due to the congenital¬†<strong>absence</strong>¬†of bilateral¬†<strong>vas</strong>¬†<strong>deferens</strong>¬†and defective sperm transport, resulting in¬†<strong>obstructive azoospermia. Females</strong>¬†have infertility due to abnormalities of the reproductive tract secretions.</li>\n</ul>\n<p>¬†The¬†<strong>diagnosis</strong>¬†is¬†<strong>confirmed</strong>¬†if¬†<strong>both</strong>¬†of the following¬†<strong>criteria</strong>¬†are met:</p>\n</div>\n</div>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<ul>\n<li>Presence of\n<ul>\n<li><strong>Clinical symptoms</strong>¬†affecting at least one organ system (respiratory, gastrointestinal, or genitourinary)¬†<strong>or</strong></li>\n<li>Positive<strong>¬†newborn screening</strong>¬†<strong>or</strong></li>\n<li>A¬†<strong>sibling</strong>¬†with cystic fibrosis</li>\n</ul>\n</li>\n<li>Evidence of¬†<strong>dysfunction</strong>¬†of the¬†<strong>CFTR gene</strong>¬†by\n<ul>\n<li><strong>Two positive sweat chloride tes</strong>t results were obtained on separate days¬†<strong>or</strong></li>\n<li>Identification of¬†<strong>two CFTR mutations</strong>¬†by genetic testing¬†<strong>or</strong></li>\n<li>An¬†<strong>abnormal</strong>¬†measurement of¬†<strong>nasal potential difference</strong></li>\n</ul>\n</li>\n</ul>\n<p>Cystic fibrosis requires a multidisciplinary approach to management. The correction of the defect can be via:</p>\n<ul>\n<li><strong>Lumacaftor,</strong>¬†an FDA-approved drug that corrects the misfolding and reverts the Phe508del mutation defect</li>\n<li><strong>Ivacaftor</strong>¬†potentiates CFTR channel opening and stimulates ion transport</li>\n</ul>\n<p>End-stage pulmonary failure requires¬†<strong>lung transplantation</strong>.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div class=\"row mt-3\">¬†</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1184",
      "difficulty": "easy"
    },
    {
      "text": "One-day-old term neonate presented with respiratory distress, tachypnea, SpO2-80%, and scaphoid abdomen. Which of the following cannot be used in resuscitation?",
      "choices": [
        {
          "id": 1,
          "text": "Positive pressure ventilation"
        },
        {
          "id": 2,
          "text": "Endotracheal intubation"
        },
        {
          "id": 3,
          "text": "Bag and mask ventilation"
        },
        {
          "id": 4,
          "text": "Oxygen suplementation"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario of a one-day term-old neonate presented with respiratory distress, tachypnea, SpO2-80%, and scaphoid abdomen is suggestive of <strong>congenital diaphragmatic hernia. Bag and mask ventilation</strong>¬†is to be¬†<strong>avoided</strong>¬†in the management of this baby.¬†Bag and mask ventilation may increase abdominal distension and limit the expansion of the hypoplastic lungs.¬†</p>\n<p><strong>Congenital diaphragmatic hernia (CDH)¬†</strong>is a birth defect of the diaphragm. Malformation of the diaphragm allows the abdominal organs to push into the chest cavity, hindering proper lung formation and resulting in pulmonary hypoplasia. The most common type of CDH is a¬†<strong>Bochdalek</strong>¬†<strong>hernia and¬†</strong>in most cases involves the¬†<strong>left side</strong>.<strong>¬†</strong>CDH is a life-threatening pathology in infants and a major cause of morbidity and mortality due to two complications:¬†<strong>pulmonary</strong>¬†<strong>hypoplasia</strong>¬†and¬†<strong>pulmonary</strong>¬†<strong>hypertension</strong>.</p>\n<p>Babies with CDH present with¬†<strong>respiratory distress</strong>¬†characterized by tachypnea, grunting, use of accessory muscles, and cyanosis. They may also have a scaphoid abdomen and increased chest wall diameter. Auscultation of the chest may reveal bowel sounds with reduced breath sounds.</p>\n<p>Diagnosis: A chest radiograph and nasogastric tube passage can confirm the diagnosis of CDH. Prenatal diagnosis can be made using ultrasonography between 16 to 24 weeks of gestation. High-speed fetal magnetic resonance imaging (MRI) can further define the lesion.</p>\n<p><strong>Management of CDH:</strong></p>\n<p>The¬†<strong>immediate step</strong>¬†in the management is the<strong>¬†naso- or orogastric tube</strong>¬†placement for¬†<strong>decompression.¬†</strong>The¬†<strong>airway</strong>¬†is to be<strong>¬†secured</strong>¬†with¬†<strong>endotracheal intubation¬†</strong>and respiratory distress is stabilised.¬†</p>\n<p>Inhaled<strong>¬†nitric oxide</strong>¬†is used widely for its pulmonary¬†<strong>vasodilatory effect</strong>.¬†<strong>Conventional mechanical ventilation</strong>,¬†<strong>high-frequency oscillatory ventilation</strong>¬†(HFOV), and¬†<strong>extracorporeal membrane oxygenation</strong>¬†(ECMO) are the 3 main strategies to support<strong>¬†respiratory failure</strong>¬†in newborn with CDH<strong>.¬†</strong></p>\n<p><strong>Surgical repair</strong>¬†of the defect is to be considered at least¬†<strong>48 hours after stabilization</strong>¬†and resolution of pulmonary hypertension. During surgery, the viscera are reduced into the abdominal cavity, and the posterolateral defect in the diaphragm is closed using interrupted, nonabsorbable sutures.</p>\n<p>¬†</p><hr><h3>Related Pearl: Congenital diaphragmatic hernias (CDH)</h3><div class=\"page\" title=\"Page 959\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 1892\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 1892\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>It is due to<strong>&nbsp;</strong>the <strong>failure of the closure of the pleuroperitoneal canal</strong> in the developing fetus (Normally the pleuroperitoneal cavities separate by 8-10 weeks of gestation). <strong>Left-sided </strong>hernias are<strong>&nbsp;</strong>more <strong>common</strong>(80%).</p>\n<p>The two well-recognized congenital sites where abdominal viscera can herniate into the chest are:</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<ul>\n<li><strong>The foramen of Morgagni</strong>: a hernia in the <strong>anteromedial</strong>&nbsp;part of the diaphragm with a defect between the sternal and costal attachments. The most commonly involved viscus is the <strong>transverse colon.</strong></li>\n<li><strong>The foramen of Bochdalek</strong>: through the dome of the diaphragm<strong> posterolaterally</strong></li>\n</ul>\n<p>CDH causes <strong>pulmonary hypoplasia (bilateral) </strong>by compressing the developing lung. These lungs have smaller bronchi, with less bronchial branching and less alveolar surface area than lungs in normal infants. Pulmonary hypertension may also develop due to increased thickness of arteriolar smooth muscle and also by&nbsp;multiple local and systemic vasoactive factors.</p>\n<p><strong>Clinical features:</strong></p>\n<div class=\"page\" title=\"Page 1892\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>respiratory distress at birth</li>\n<li>grunting respiration</li>\n<li>chest retractions</li>\n<li>dyspnea</li>\n<li>cyanosis</li>\n<li>scaphoid abdomen</li>\n<li>decreased breath sounds along with bowel sound over the chest with CDH</li>\n<li>shifting of heart sounds to the right (for left-sided CDH)</li>\n</ul>\n<div class=\"section\">&nbsp;</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f4f1fdad64d24053b439a528cf873989x1280x1660.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1228",
      "difficulty": "easy"
    },
    {
      "text": "A child with type 1 DM presents with acidosis, and blood sugar 400 mg/dl. What is the further management?",
      "choices": [
        {
          "id": 1,
          "text": "IV insulin stat"
        },
        {
          "id": 2,
          "text": "Normal saline with SC insulin stat"
        },
        {
          "id": 3,
          "text": "Normal saline followed by insulin infusion after 1 hour"
        },
        {
          "id": 4,
          "text": "Normal saline and insulin infusion immediately"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>A given clinical scenario of a child with type 1 diabetes mellitus (DM) presenting with<strong> acidosis</strong> and a <strong>high blood sugar level</strong> (hyperglycemia) describes a scenario suggestive of <strong>diabetic ketoacidosis</strong> (DKA), a serious complication of uncontrolled diabetes. the further management would be¬†<strong>Normal saline followed by insulin infusion after 1 hour.¬†</strong></p>\n<p>The International Society for Pediatric and Adolescent Diabetes (<strong>ISPAD</strong>) guidelines provide evidence-based recommendations for the management of¬†<strong>DKA</strong>¬†(diabetic ketoacidosis) in¬†<strong>children</strong>¬†<strong>and adolescents.¬†</strong></p>\n<p><strong>Diabetic ketoacidosis¬†</strong>is the most serious complication of type 1 diabetes mellitus. Clinical manifestations of diabetic ketoacidosis include:</p>\n<div class=\"page\" title=\"Page 3\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li><strong>Dehydration</strong>,¬†<strong>tachypnea</strong>¬†with deep, sighing respiration (<strong>Kussmaul breathing</strong>)</li>\n<li><strong>Nausea, vomiting</strong>, and¬†<strong>abdominal pain</strong>¬†that may mimic an acute abdominal condition</li>\n<li><strong>Confusion</strong>, drowsiness, and coma in severe cases.</li>\n</ul>\n<p>The diagnosis of DKA is based on the triad of hyperglycemia, ketosis, and metabolic acidosis. All three biochemical criteria are required to diagnose DKA</p>\n</div>\n</div>\n</div>\n</div>\n<ul>\n<li><strong>Hyperglycemia</strong>¬†(blood glucose¬†<strong>&gt;200 mg/dl</strong>)</li>\n<li>Venous¬†<strong>pH &lt; 7.3</strong>¬†or serum bicarbonate &lt;18 mmol/L</li>\n<li><strong>Ketonemia</strong>¬†or¬†<strong>ketonuria</strong></li>\n</ul>\n<div class=\"page\" title=\"Page 2\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 1\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Initial management includes management of the<strong>¬†airway, breathing,</strong>¬†and¬†<strong>circulation</strong>¬†(ABC) according to¬†Pediatric Advanced Life Support (PALS) guidelines. Following that emergency assessment is done, which includes:</p>\n<ul>\n<li>Immediate measurement of blood glucose, blood or urine ketones, serum electrolytes and blood gases</li>\n<li>Assessment of level of consciousness.</li>\n<li>Two peripheral intravenous (IV) lines should be inserted.</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n<p>The goal of therapy is to¬†<strong>correct dehydration</strong>,¬†<strong>correct acidosis</strong>,¬†<strong>reverse ketosis</strong>, and gradually blood glucose concentration to near normal. Monitor for acute complications, and identify and treat any precipitating event.</p>\n<div class=\"page\" title=\"Page 2\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Fluid replacement should always begin before starting insulin therapy. One or more boluses of¬†<strong>0.9% saline</strong> at <strong>10-20 mL/kg¬†</strong>are given<strong>¬†</strong>to restore peripheral circulation.¬†<strong>Insulin therapy</strong>¬†with<strong>¬†0.05‚Äì0.1 U/kg/hr</strong>¬†must begin¬†<strong>at least 1 hour after</strong>¬†starting fluid replacement therapy. Insulin of¬†<strong>0.05 U/kg/hr</strong>¬†can be considered if¬†<strong>pH</strong>¬†is¬†<strong>&gt; 7.15</strong>.</p>\n<p><strong>Potassium replacement</strong>¬†is given only when potassium is¬†<strong>&lt;5.5 mmol/L</strong>. In rare cases of<strong>¬†hypokalemia</strong>¬†with potassium¬†<strong>&lt;3.0</strong>¬†mmol/L,¬†<strong>defer insulin treatment</strong>.</p>\n<div class=\"page\" title=\"Page 2\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Bicarbonate</strong>¬†administration is not recommended except for treatment of¬†<strong>severe acidosis</strong>¬†(pH &lt; 6.9) or in cases of¬†life-threatening hyperkalemia.¬†</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3bd9e1e7228e4ca0bf552de377af0dcax1280x2847.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Comparative Features of Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>DKA</strong></p>\n</td>\n<td>\n<p><strong>HHS</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Seen in </strong></p>\n</td>\n<td>\n<p>Type 1 DM</p>\n</td>\n<td>\n<p>Type 2 DM</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Clinical features</strong></p>\n</td>\n<td>\n<p>Abdominal pain</p>\n<p>Kussmaul respiration</p>\n<p>Fruity odour of breath</p>\n</td>\n<td>\n<p>Altered sensorium</p>\n<p>Coma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Glucose (mg/dL)</strong></p>\n</td>\n<td>\n<p>250&ndash;600</p>\n</td>\n<td>\n<p>600&ndash;1200</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Sodium</strong></p>\n</td>\n<td>\n<p>120&ndash;125</p>\n</td>\n<td>\n<p>135&ndash;145</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Osmolality </strong></p>\n</td>\n<td>\n<p>300&ndash;320</p>\n</td>\n<td>\n<p>330&ndash;380</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Plasma Ketones</strong></p>\n</td>\n<td>\n<p>++++</p>\n</td>\n<td>\n<p>+/-</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Serum Bicarbonate</strong></p>\n</td>\n<td>\n<p>&lt; 15 meq/ L</p>\n</td>\n<td>\n<p>Normal to slightly &darr;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Arterial pH </strong></p>\n</td>\n<td>\n<p>6.8&ndash;7.3</p>\n</td>\n<td>\n<p>&gt;7.3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Arterial pCO<sub>2 </sub>(mmHg)</strong></p>\n</td>\n<td>\n<p>20&ndash;30</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Anion Gap</strong></p>\n</td>\n<td>\n<p><strong>&uarr;</strong></p>\n</td>\n<td>\n<p>Normal to slightly &uarr;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1232",
      "difficulty": "easy"
    },
    {
      "text": "A 9-month-old child is brought to the PHC with a fever and cough. She is feeding well and has normal urine output. On examination, a respiratory rate of 48 breaths/min is found and no chest indrawing is seen. What is the next step of management?",
      "choices": [
        {
          "id": 1,
          "text": "Explain danger signs and send home"
        },
        {
          "id": 2,
          "text": "No pneumonia - Give amoxyclav + paracetamol and send home"
        },
        {
          "id": 3,
          "text": "Start IV ceftriaxone"
        },
        {
          "id": 4,
          "text": "Refer as the child has severe pneumonia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In the given clinical scenario, a 9-month-old child with normal breathing (<strong>&gt;&nbsp;50/min</strong>&nbsp;RR for infants&nbsp;<strong>2 months&nbsp;</strong>to<strong>&nbsp;12 months </strong>is considered as <strong>fast breathing) </strong>and no chest indrawing is seen. So, the next step in management would be to&nbsp;<strong>explain danger signs and send them home.</strong></p>\n<p>According to the<strong>&nbsp;</strong>IMNCI, three<strong>&nbsp;</strong>key clinical&nbsp;<strong>signs</strong>&nbsp;are used to assess a sick child with suspected pneumonia:</p>\n<ul>\n<li><strong>Respiratory rate</strong>&nbsp;(RR):<strong>&nbsp;d</strong><strong>istinguishes</strong>&nbsp;children who have&nbsp;<strong>pneumonia</strong>&nbsp;from those who do not. Children are classified under pneumonia if:\n<ul>\n<li><strong>&gt;&nbsp;60 breaths</strong>&nbsp;per minute if age &nbsp;is&nbsp;<strong>&lt; 2 months&nbsp;</strong></li>\n<li><strong>&gt;&nbsp;50/min</strong>&nbsp;RR for infants&nbsp;<strong>2 months&nbsp;</strong>to<strong>&nbsp;12 months</strong></li>\n<li><strong>&gt;&nbsp;40/min</strong>&nbsp;RR for children&nbsp;<strong>12 months</strong>&nbsp;to&nbsp;<strong>5 years</strong>&nbsp;of age</li>\n</ul>\n</li>\n<li><strong>Lower chest wall indrawing</strong>&nbsp;refers to the indrawing of the lower chest wall with respect to the child's breathing and indicates&nbsp;<strong>pneumonia</strong></li>\n<li><strong>Stridor&nbsp;</strong>indicates those with&nbsp;<strong>severe pneumonia</strong>&nbsp;requiring hospital<strong>&nbsp;admission.</strong></li>\n</ul>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p>The revised classification of acute respiratory&nbsp;infections is simplified to include only two categories of pneumonia:</p>\n<ul>\n<li>Cough and cold, no pneumonia - requires home remedy</li>\n<li>Pneumonia - with&nbsp;<strong>fast breathing&nbsp;</strong>and/or&nbsp;<strong>chest indrawing</strong>, which requires&nbsp;<strong>home therapy</strong>&nbsp;with&nbsp;<strong>oral amoxicillin</strong>.</li>\n<li>Severe pneumonia - pneumonia with&nbsp;<strong>any general danger sign</strong>, which&nbsp;<strong>requires</strong>&nbsp;a&nbsp;<strong>referral</strong>&nbsp;and&nbsp;<strong>injectable therapy</strong>.&nbsp;</li>\n</ul>\n</div>\n</div>\n<div class=\"ng-scope\"><strong>Danger signs&nbsp;</strong>of severe pneumonia are:&nbsp;</div>\n<ul>\n<li>Not able to drink</li>\n<li>Persistent vomiting</li>\n<li>Convulsions</li>\n<li>Lethargic or unconscious</li>\n<li>Stridor in a calm child</li>\n<li>Severe malnutrition</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/402ec23059f642f1840119590a5d55fdx1280x711.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1227",
      "difficulty": "medium"
    }
  ]
}